Six things to know:
1. Net sales were $196.6 million.
2. U.S. spinal fixation sales grew 18% year over year, and U.S. orthopedic sales grew 15% year over year.
3. The company entered a record number of 7D Flash navigation system earnout agreements and matched its record for the most 7D placements in any quarter to date.
4. Orthofix reported free cash flow of $5.9 million but also saw a net loss of $27.4 million.
5. Orthofix is maintaining its full-year sales trajectory of $795 million to $800 million.
6. There are also three new financial targets for 2025 through 2027: 6% to 7% net sales growth, mid-teens non-GAAP adjusted EBITDA and positive free cash flow generation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
